|
Dr. Reddy's Laboratories launches Zafirlukast tablets in US
Trading Markets (press release) … Laboratories (NYSE: RDY | PowerRating) reported on Saturday the launch of its Zafirlukast tablets (10mg and 20mg) in the US market, for treating asthma. … Dr Reddy's gets USFDA nod Dr. Reddy's launches generic Accolate Dr Reddy's gets FDA nod to launch Zafirlukast in US |
View full post on asthma – Google News